- U.S. stock futures showed gains this morning, particularly the Nasdaq 100 futures which rose over 2% on Thursday.
- H.B. Fuller Company reported strong second-quarter earnings, raised its FY2026 outlook, and announced an acquisition offer, yet its shares fell 8.3% to $59.27 in pre-market trading.
- Several other stocks, including ARS Pharmaceuticals and Trip.com Group, also experienced significant declines in pre-market trading due to various negative forecasts and announcements.
